clinical use

23 triples
GPTKB property

Random triples
Subject Object
gptkb:butyrylcholinesterase assessment of exposure to nerve agents
gptkb:matrix_metalloproteinases biomarkers for disease
gptkb:lysosomal_acid_alpha-glucosidase enzyme replacement therapy for Pompe disease
gptkb:maytansine not used as a single agent due to toxicity
gptkb:DKK1_gene biomarker for bone disease
gptkb:butyrylcholinesterase diagnosis of liver function
gptkb:DKK1_gene potential therapeutic target
gptkb:adenosine_deaminase marker for immune function
gptkb:human_carbonic_anhydrase_II target for glaucoma drugs
gptkb:Insulin-like_growth_factor_I diagnosis of growth disorders
gptkb:Insulin-like_growth_factor_II biomarker for certain cancers
gptkb:Aspartate_transaminase marker for myocardial infarction
gptkb:Insulin-like_growth_factor_I monitoring growth hormone therapy
gptkb:hsa:3630 target of sarilumab
gptkb:Aspartate_aminotransferase marker for myocardial infarction
gptkb:adenosine_deaminase diagnosis of tuberculosis (pleural fluid ADA test)
gptkb:hsa:3630 target of tocilizumab
gptkb:Aspartate_aminotransferase marker for liver damage
gptkb:butyrylcholinesterase identification of atypical enzyme variants
gptkb:glucocerebrosidase enzyme replacement therapy